Extracorporeal photopheresis in combination with bexarotene in the treatment of mycosis fungoides and Sézary syndrome.
Tsirigotis
P
P
Pappa
V
V
Papageorgiou
S
S
Kapsimali
V
V
Giannopoulou
V
V
Kaitsa
I
I
Girkas
K
K
Papageorgiou
E
E
Stavrianeas
N
N
Economopoulos
T
T
Dervenoulas
J
J
D000368:Aged; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D000077610:Bexarotene; D003131:Combined Modality Therapy / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000188:drug therapy*; D017893:Photopheresis / Q000379:methods*; D012751:Sezary Syndrome / Q000188:drug therapy*; D013764:Tetrahydronaphthalenes / Q000627:therapeutic use*
D016588:Anticarcinogenic Agents; D013764:Tetrahydronaphthalenes; D000077610:Bexarotene